The Consumer & Leisure sector is a longstanding area of focus for Trilantic Europe. Investments in the sector have been made by each of our last three Funds, dating back to 2003. Utilising the broad expertise of our team and of our operating Partners, we focus particularly on Food and Food Ingredients, Beauty Products, Luxury and Leisure & Entertainment.
Our portfolio companies typically have strong brands and market positioning, while those in the leisure segment enjoy positive market dynamics driven by demographics and consumption/experience trends.
Trilantic Europe has a long history of investing in Industrial companies often backing family or founder owned businesses as they undergo intergenerational transitions, international expansion or spin-off from larger industrial conglomerates. With a strong base of Industrial, Manufacturing and Engineering companies in Europe, Trilantic Europe has in particular focused on transportation, automotive and energy efficient solutions.
Historically, Trilantic Europe has closely monitored the Telecom sector in Europe and been able to support companies at times where hands-on value-added capital was required to support investments, growth or operational improvements. Our commitment to Telecom and Media has recently been complemented by increased focus on Technology, Software and Internet related businesses.
Trilantic Europe typically focuses on asset light companies with high cash conversion rates, and significant potential for international expansion that we can support. Buy and Build has been a particularly relevant strategy for this sector.
Healthcare expenditure represents between 9% and 11% of GDP in all European countries. With positive macro trends in Europe, including ageing populations, increased life expectancy and growing government deficits in some countries, Trilantic Europe continues to actively search for opportunities in the sector.
Our deep-rooted presence in each of the geographies we target, together with our strong industry expertise supported by 3 operating partners, means we are well positioned to invest in the complex European healthcare landscape. Differing payment, regulatory and social factors create unique characteristics in each country and provide an opportunity for us to employ our specialist knowledge and expertise. Trilantic Europe has been particularly active in Medical Services and Facilities, but also in Pharma Ingredients and Contract Manufacturing where we believe there are good consolidation opportunities for companies that can offer efficient manufacturing and operational standards.